Literature DB >> 18024887

Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy.

Paola Ghiorzo, Sara Gargiulo, Sabina Nasti, Lorenza Pastorino, Linda Battistuzzi, William Bruno, Luigina Bonelli, Paola Taveggia, Vittorio Pugliese, Giacomo Borgonovo, Luca Mastracci, Giuseppe Fornarini, Paola Romagnoli, Elena Iiritano, Vincenzo Savarino, Giovanna Bianchi-Scarrà.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 18024887     DOI: 10.1200/JCO.2007.13.5624

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

Review 2.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Epidemiological and genetic factors underlying melanoma development in Italy.

Authors:  Giuseppe Palmieri; Maria Colombino; Milena Casula; Mario Budroni; Antonella Manca; Maria Cristina Sini; Amelia Lissia; Ignazio Stanganelli; Paolo A Ascierto; Antonio Cossu
Journal:  Melanoma Manag       Date:  2015-05-18

4.  Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.

Authors:  P Ghiorzo; V Pensotti; G Fornarini; S Sciallero; L Battistuzzi; F Belli; L Bonelli; G Borgonovo; W Bruno; A Gozza; S Gargiulo; L Mastracci; S Nasti; G Palmieri; F Papadia; L Pastorino; A Russo; V Savarino; L Varesco; L Bernard; G Bianchi Scarrà
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

5.  Negative methylation status of vimentin predicts improved prognosis in pancreatic carcinoma.

Authors:  Yi-Feng Zhou; Wei Xu; Xia Wang; Jin-Shan Sun; Jing-Jing Xiang; Zhao-Shen Li; Xiao-Feng Zhang
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.

Authors:  Robert R McWilliams; Eric D Wieben; Kari G Rabe; Katrina S Pedersen; Yanhong Wu; Hugues Sicotte; Gloria M Petersen
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

Review 7.  Selection criteria for genetic assessment of patients with familial melanoma.

Authors:  Sancy A Leachman; John Carucci; Wendy Kohlmann; Kimberly C Banks; Maryam M Asgari; Wilma Bergman; Giovanna Bianchi-Scarrà; Teresa Brentnall; Brigitte Bressac-de Paillerets; William Bruno; Clara Curiel-Lewandrowski; Femke A de Snoo; Tadeusz Debniak; Marie-France Demierre; David Elder; Alisa M Goldstein; Jane Grant-Kels; Allan C Halpern; Christian Ingvar; Richard F Kefford; Julie Lang; Rona M MacKie; Graham J Mann; Kurt Mueller; Julia Newton-Bishop; Håkan Olsson; Gloria M Petersen; Susana Puig; Darrell Rigel; Susan M Swetter; Margaret A Tucker; Emanuel Yakobson; John A Zitelli; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2009-10       Impact factor: 11.527

Review 8.  KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer.

Authors:  Jonas Cicenas; Kotryna Kvederaviciute; Ingrida Meskinyte; Edita Meskinyte-Kausiliene; Aiste Skeberdyte; Jonas Cicenas
Journal:  Cancers (Basel)       Date:  2017-04-28       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.